Cargando...
Pre‐clinical validation of a selective anti‐cancer stem cell therapy for Numb‐deficient human breast cancers
The cell fate determinant Numb is frequently downregulated in human breast cancers (BCs), resulting in p53 inactivation and an aggressive disease course. In the mouse mammary gland, Numb/p53 downregulation leads to aberrant tissue morphogenesis, expansion of the stem cell compartment, and emergence...
Gardado en:
| Publicado en: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5412856/ https://ncbi.nlm.nih.gov/pubmed/28298340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201606940 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|